From Eleusis to FDA Approval: The 4,000-Year History of Psychedelics

Before History

The use of psychoactive plants predates human civilization itself. Archaeological evidence suggests that psychedelic mushrooms, peyote, ayahuasca, and cannabis were used by our ancestors for at least 7,000 years — possibly much longer.

The oldest confirmed evidence of psychedelic use comes from:

• Algeria (7,000-9,000 BCE): Cave paintings in Tassili n'Ajjer depict mushroom-headed figures interpreted by ethnomycologists as representations of psilocybin mushroom rituals.
• Mexico (3,780 BCE): Radiocarbon-dated peyote buttons found in the Shumla Caves of Texas, preserved in a context suggesting ritual use.
• Andes (2,000 BCE): Residue analysis of pipes from the Tiwanaku civilization contains traces of DMT, bufotenine, and possibly psilocin.

The Eleusinian Mysteries (1600 BCE - 392 CE)

The most historically significant psychedelic ritual in Western civilization was the Eleusinian Mysteries, conducted near Athens for nearly 2,000 years. Initiates drank a preparation called *kykeon*, which scholars — including Albert Hofmann himself — have argued almost certainly contained an LSD-like ergot alkaloid.

The ceremony was so profound that participants universally reported losing their fear of death. Plato, Aristotle, Sophocles, and Marcus Aurelius were all initiates.

The Mysteries were shut down in 392 CE when Emperor Theodosius outlawed pagan rituals. The knowledge of kykeon's preparation was lost — a 2,000-year psychedelic tradition extinguished by imperial decree.

Mesoamerican Traditions: Psilocybin, Peyote, and Morning Glory

When Spanish conquistadors arrived in Mexico in 1519, they encountered three distinct psychedelic traditions:

1. Teonanácatl ("Flesh of the Gods"): Psilocybin mushrooms used by Aztec priests for divination and healing. The Spanish suppressed these rituals with extreme violence — declaring mushroom ceremonies heresy punishable by death. The tradition survived in remote mountain communities for 400 years until R. Gordon Wasson documented an active ceremony in 1955, bringing psilocybin to Western attention.

1. Peyote (Lophophora williamsii): Used by the Huichol, Tarahumara, and other indigenous groups in Mexico and the American Southwest. Unlike mushroom ceremonies, peyote rituals survived Spanish persecution more successfully and were practiced continuously into the modern era. The Native American Church, which combines peyote ceremony with Christian elements, was formally incorporated in 1918.

1. Ololiuqui (Morning Glory seeds): *Turbina corymbosa* seeds containing LSA (lysergic acid amide, a close chemical relative of LSD) were used in divination rituals. Albert Hofmann later confirmed LSA's psychoactive properties in 1960, demonstrating that Mesoamerican peoples had identified a compound structurally identical to the core of the LSD molecule — centuries before Western chemistry understood it.

Ayahuasca: The Vine of the Soul

In the Amazon basin, indigenous peoples developed one of the most sophisticated pharmacological technologies in human history: ayahuasca, a brew combining the *Banisteriopsis caapi* vine (containing MAOIs) with DMT-containing plants like *Psychotria viridis*.

The brilliance of this combination is that DMT is not orally active on its own — stomach enzymes (MAO) break it down before it reaches the brain. The vine contains MAO inhibitors that temporarily disable those enzymes, allowing the DMT to take effect.

This requires knowledge of which two specific plants to combine, in what proportions, and how to prepare them — knowledge that could only have been developed through systematic experimentation over centuries. The Amazonian peoples who developed ayahuasca were, in effect, pharmacologists working without the tools of modern chemistry.

The Modern Era: Hofmann, Leary, and the Laboratory

1938: Albert Hofmann synthesizes LSD-25 at Sandoz Laboratories in Basel, Switzerland. It was the 25th compound in a systematic study of ergot alkaloids.

April 19, 1943 ("Bicycle Day"): Hofmann accidentally absorbs a small amount of LSD through his skin and experiences the world's first LSD trip. Three days later, he deliberately doses himself with 250 micrograms — a massive dose by modern standards — and cycles home through the streets of Basel while reality dissolves around him. His laboratory notes from that day are remarkably coherent given what he was experiencing.

1947: Sandoz begins marketing LSD under the trade name Delysid, promoting it as a tool for psychiatrists to better understand their patients and as an adjunct to psychoanalysis.

1957: R. Gordon Wasson publishes "Seeking the Magic Mushroom" in *Life* magazine, introducing psilocybin mushrooms to a mass American audience for the first time.

1958: Albert Hofmann isolates psilocybin from mushrooms provided by Wasson, determining its chemical structure and developing a synthesis method.

1960-1965: LSD and psilocybin are studied at Harvard (Timothy Leary, Richard Alpert), Johns Hopkins, and dozens of other institutions. Over 1,000 clinical papers are published on psychedelic therapy, with promising results for alcoholism, anxiety, and end-of-life distress.

1966: LSD is criminalized in California, followed by federal prohibition in 1968. Clinical research grinds to a halt for nearly 30 years.

The Renaissance (2006-Present)

In 2006, Roland Griffiths at Johns Hopkins published a landmark study showing that psilocybin produced profound mystical experiences with lasting positive effects in healthy volunteers. The paper — in the journal *Psychopharmacology* — effectively restarted psychedelic research after a four-decade hiatus.

By 2026:

• MDMA-assisted therapy for PTSD received FDA breakthrough therapy designation (2017) and is expected to receive full approval
• Psilocybin therapy for depression has completed Phase II trials with significant results
• Oregon and Colorado have legalized psilocybin for therapeutic use
• Australia became the first country to approve MDMA and psilocybin as medicines (2023)
• Over 100 clinical trials of psychedelic compounds were active worldwide

The 4,000-year arc of human psychedelic use — from Eleusis to the FDA — reflects a fundamental truth: altered states of consciousness have always been part of the human experience. The question has never been whether we will use these substances, but how safely and intentionally we will do so.